| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 98,789 | 104,175 | 99,217 | 93,872 | | Cost of Revenue | 28,308 | 30,353 | 28,297 | 25,234 | | | Gross Profit | 70,481 | 73,822 | 70,920 | 68,638 | | | Operating Expenses | | Research Development | 22,464 | 21,785 | 24,436 | 23,202 | | Selling General and Administrative | 47,359 | 45,909 | 53,595 | 47,899 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 658 | 6,128 | (7,111) | (2,463) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 152 | 733 | 1,170 | (21) | | Earnings Before Interest And Taxes | 810 | 6,861 | (5,941) | (2,484) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 810 | 6,861 | (5,941) | (2,484) | | Income Tax Expense | 4,007 | 3,051 | (2,593) | 1,713 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,197) | 3,810 | (3,348) | (4,197) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,197) | 3,810 | (3,348) | (4,197) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,197) | $3,810 | ($3,348) | ($4,197) |
|
0.11% Nasdaq 0.00%
Income Statement
